AzTrials
AzTrials

Cannabis UseCARSNCT05486234

CARS: Cannabis and Alcohol Reduction Study

A study testing modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias and modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias. in people with Cannabis Use and Alcohol Use, Unspecified, run by Medical University of South Carolina at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study will test a computerized treatment with subjects ages 13-17 years who are seeking treatment for alcohol and/or cannabis use. Follow-up assessments will be conducted at one- and three-months following treatment. Read more about this study

Who is it for?
Ages 13 to 17 years
What is being tested?
modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias and modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
52 participants
Where
1 siteUnited States
Study dates
25 Jan 2023to 1 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • between the ages of 13 and 17
  • be seeking treatment for either cannabis or alcohol use;
  • report co-occurring alcohol and cannabis use during the past three months (i.e., participants who report using both alcohol and cannabis during the three months prior to participation in the study, regardless of if the use was simultaneous)
  • have a caregiver willing to participate and provide consent.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Austin M Hahn, Ph.D. contact

854-444-9456

hahna@musc.edu

United States1 site, 1 recruiting
  • Medical University of South Carolina

    Charleston, South Carolina, 29425

    Austin Hahn, Ph.D., 854-444-9456

    Recruiting

Other trials in United States

About this study

Official title: Brief Computerized Intervention for Reducing Adolescent Cannabis and Alcohol Use

The study will test a computerized treatment with subjects ages 13-17 years who are seeking treatment for alcohol and/or cannabis use. Follow-up assessments will be conducted at one- and three-months following treatment.

Being tested
modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias, modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.
Medical subject headings
Alcohol Drinking, Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach biasBehavioural

    Participants will undergo a baseline assessment before completing computerized tasks. During the baseline assessment, participants will be asked questions about alcohol and cannabis use. We will also ask questions about the way participants think about things, past life experiences related to substance use, and questions about how participants feel about reducing their substance use. Then, participants will complete a series computerized tasks where they will push and pull a joystick in response to images that are presented on a screen or where they will try to get a high score. During the computerized tasks, we will also be measuring brain activity using EEG. During the study, participants will also be asked to respond to questions about their health and behavior using an app on a smartphone or tablet using a secure program. Participants in the Treatment Group will then complete four sessions of the modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias.

  • modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.Behavioural

    Participants will undergo a baseline assessment before completing computerized tasks. During the baseline assessment, participants will be asked questions about alcohol and cannabis use. We will also ask questions about the way participants think about things, past life experiences related to substance use, and questions about how participants feel about reducing their substance use. Then, participants will complete a series computerized tasks where they will push and pull a joystick in response to images that are presented on a screen or where they will try to get a high score. During the computerized tasks, we will also be measuring brain activity using EEG. During the study, participants will also be asked to respond to questions about their health and behavior using an app on a smartphone or tablet using a secure program. Participants in the Control Group will then complete four sessions of an Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.

Study groups in NCT05486234
Study groupRoleWhat they receive
Group A: Treatment GroupExperimentalNot described
Receives: Behavioral: modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias
Group B: Control GroupSham comparatorNot described
Receives: Behavioral: modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in cannabis use as assessed by Timeline Followback

    The TLFB is a calendar-assisted semi-structured interview that will be used to assess cannabis and alcohol use since the last assessment. The TLFB will assess the number of days a person used cannabis over the past 90 days compared to the 90 days prior to enrolling in this study.

    Measured: Baseline and Three-Month Follow-up

  2. Change in alcohol use as assessed by Timeline Followback

    The TLFB is a calendar-assisted semi-structured interview that will be used to assess cannabis and alcohol use since the last assessment. The TLFB will assess the number of days a person consumed alcohol over the past 90 days compared to the 90 days prior to enrolling in this study.

    Measured: Baseline and Three-Month Follow-up

  3. Change in Cannabis Approach Bias (D-Score)

    D scores will be calculated for each participant at baseline, posttest, and three-month follow-up. Participants' mean reaction times (RTs) during the approach cannabis trials will be subtracted from the mean avoid cannabis trial RTs. These scores are then divided by the SD across all cannabis trials. Positive scores indicate an approach bias for cannabis stimuli.

    Measured: Baseline, One-Week Follow-up, and Three-Month Follow-up

  4. Change Cannabis Approach Bias (D-Score)

    D scores will be calculated for each participant at baseline, posttest, and three-month follow-up. Participants' mean reaction times (RTs) during the approach alcohol trials will be subtracted from the mean avoid alcohol trial RTs. These scores are then divided by the SD across all alcohol trials. Positive scores indicate an approach bias for alcohol stimuli.

    Measured: Baseline, One-Week Follow-up, and Three-Month Follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2022
  2. Study start25 Jan 2023
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion1 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05486234
Sponsor's protocol ID
00106723
Other IDs
1K23DA050800-01A1
Acronym
CARS
Status last verified
Aug 2026
First submitted
1 Aug 2022
Last updated
13 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing modified Approach-Avoidance Task (mAAT), which aims to modify automatic approach bias and modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias. in people with Cannabis Use and Alcohol Use, Unspecified, run by Medical University of South Carolina at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Austin M Hahn, Ph.D. (854-444-9456, hahna@musc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in cannabis use as assessed by Timeline Followback (time frame: Baseline and Three-Month Follow-up). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in